What question did this study set out to answer?

To determine the prevalence and clinical correlates of lipid-lowering drug use among older men with established coronary heart disease.

July 1, 2002HeartOpen Access

Low prevalence of lipid lowering drug use in older men with established coronary heart disease

View Full Paper

Ask AI

Bookmark

Why the study?

What is the prevalence of lipid lowering drug use among older British men with established coronary heart disease?

Population

3,689 men aged 60-75 years from 24 British towns, including 286 with definite myocardial infarction and 360…

Design

Cross-sectional

Follow-up

20 years

Authors

PWPeter H. WhincupPreventive Cardiology

Discussion

Member takes

Implication

Low lipid-lowering drug use persists among older British men with CHD; leaves open targeted strategies to improve secondary prevention uptake.

Key Points

To determine the prevalence and clinical correlates of lipid-lowering drug use among older men with established coronary heart disease.
Cross-sectional survey conducted during the 20-year follow-up (1998–2000) of the British Regional Heart Study across general practices in 24 British towns.
Evaluated 3,689 men aged 60–75 years using general practice records to identify diagnoses of myocardial infarction and angina, alongside measurements of blood cholesterol and medication use.
Lipid-lowering drugs were taken by 36% (102/286) of men with confirmed myocardial infarction (33% statins) and by 23% (84/360) of men with angina without infarction (21% statins).
Total cholesterol was ≥5.0 mmol/l in 87% of untreated myocardial infarction patients and 82% of untreated angina patients; among statin users, only 45% (infarction) and 47% (angina) achieved <5.0 mmol/l, with only one-third receiving trial-validated dosages.
Treatment probability was significantly higher among men with a history of revascularisation, a more recent diagnosis, and a younger age at diagnosis.

Structured PICO

What is the prevalence of lipid lowering drug use among older British men with established coronary heart disease?

Population

3,689 men aged 60-75 years from 24 British towns, including 286 with definite myocardial infarction and 360 with definite angina without myocardial infarction.

Intervention

Lipid lowering drug use (primarily statins)

Outcome

Prevalence of lipid lowering drug use and blood cholesterol concentrations

The prevalence of lipid-lowering drug use in older British men with established coronary heart disease remains low, highlighting a significant gap in secondary prevention.

Cite This Study

Peter H. Whincup (2002) studied this question.

synapsesocial.com/papers/6a87f037fc0635f4eccf00a3 https://doi.org/10.1136/heart.88.1.25

View Full Paper

Ask AI

Bookmark

Implication

Low lipid-lowering drug use persists among older British men with CHD; leaves open targeted strategies to improve secondary prevention uptake.

Low prevalence of lipid lowering drug use in older men with established coronary heart disease

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Low prevalence of lipid lowering drug use in older men with established coronary heart disease

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Also Consider